Co-Authors
This is a "connection" page, showing publications co-authored by Zi-Wei Ye and Dong-Yan Jin.
Connection Strength
3.960
-
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerg Microbes Infect. 2021 Dec; 10(1):291-304.
Score: 0.982
-
[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future]. Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25; 36(4):571-592.
Score: 0.879
-
Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020; 16(10):1686-1697.
Score: 0.872
-
SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020; 10:40.
Score: 0.218
-
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect. 2020; 9(1):558-570.
Score: 0.218
-
Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019 08; 33(8):8865-8877.
Score: 0.205
-
Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16. EMBO Rep. 2018 10; 19(10).
Score: 0.195
-
In silico structure-based discovery of a SARS-CoV-2 main protease inhibitor. Int J Biol Sci. 2021; 17(6):1555-1564.
Score: 0.059
-
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature. 2021 05; 593(7859):418-423.
Score: 0.058
-
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat Microbiol. 2020 11; 5(11):1439-1448.
Score: 0.057
-
Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Sci Adv. 2020 08; 6(35):eaba7910.
Score: 0.056
-
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19). Viruses. 2020 06 10; 12(6).
Score: 0.055
-
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol Res. 2020 09; 159:104960.
Score: 0.055
-
SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat Commun. 2019 01 10; 10(1):120.
Score: 0.050